实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (2): 191-194.doi: 10.3969/j.issn.1672-5069.2026.02.008

• 病毒性肝炎 • 上一篇    下一篇

声触诊组织量化技术联合其他指标诊断慢性乙型肝炎患者肝纤维化效能临床研究*

张卉新, 隋雪梅   

  1. 223300 江苏省淮安市 南京医科大学附属淮安第一人民医院超声科(张卉新);检验科(隋雪梅)
  • 收稿日期:2025-12-16 出版日期:2026-03-10 发布日期:2026-03-13
  • 通讯作者: 隋雪梅,E-mail:suisui19811121@126.com
  • 作者简介:张卉新,女,43岁,大学本科,副主任医师。E-mail:u2474802300aa@163.com
  • 基金资助:
    *江苏省自然科学基金资助面上项目(编号:BK20230458)

Diagnostic performance of acoustic radiation force impulse-based tissue quantification in assessing liver fibrosis in patients with chronic hepatitis B

Zhang Huixin, Sui Xuemei   

  1. Department of Ultrasound, First Peoples’ Hospital Affiliated to Nanjing Medical University, Huai'an 223000, Jiangsu Province, China
  • Received:2025-12-16 Online:2026-03-10 Published:2026-03-13

摘要: 目的 探讨超声声触诊组织量化技术检测剪切波速度(SWV)联合其他指标诊断慢性乙型肝炎(CHB)患者显著性肝纤维化的应用价值。方法 2023年6月~2025年6月我院诊断的CHB患者97例,均行肝穿刺活检,使用超声声触诊组织量化检测SWV,同时检测血清和血液学指标,计算天冬氨酸氨基转移酶/血小板比值指数(APRI)和纤维化4因子指数(FIB-4),常规检测血清透明质酸(HA)水平,应用受试者工作特征(ROC)曲线分析指标联合诊断显著性肝纤维化的效能。结果 50例显著性肝纤维化组年龄、血清ALT和AST水平均显著高于或大于,而外周血血小板计数显著低于47例非显著性肝纤维化组(P<0.05);显著性肝纤维化组SWV、APRI、FIB-4和血清HA水平分别为(2.1±0.4)m/s、(1.2±0.7)、(2.0±1.0)和132.2(95.4,210.5)ng/ml,均显著高于非显著性肝纤维化组[分别为(1.3±0.3)m/s、(0.6±0.3)、(1.0±0.4)和55.2(38.4,72.6)ng/ml,P<0.05];以SWV联合其他任一指标诊断显著性肝纤维化的AUC为0.94(95%CI:0.90~0.97),其敏感度为91.5%,特异度为86.0%。结论 采取超声声触诊组织量化技术检测SWV再联合任一常用的肝纤维化指标可帮助临床医生筛查CHB患者肝纤维化程度,以便及时采取进一步的诊断和干预措施。

关键词: 慢性乙型肝炎, 声触诊组织量化技术, 剪切波速度, 天冬氨酸氨基转移酶/血小板比值指数, 纤维化4因子指数, 透明质酸, 诊断

Abstract: Objective This study aimed to investigate diagnostic performance of acoustic radiation force impulse (ARFI)-based tissue quantification in assessing significant liver fibrosis (SLF) in patients with chronic hepatitis B (CHB). Methods A total of 97 patients with CHB were admitted to our hospital between June 2023 and June 2025, and all underwent liver biopsy. Shear wave velocity (SWV) was obtained by ARFI, aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis index based on four factors (FIB-4) were calculated. Serum hyaluronic acid (HA) level was routinely detected. Receiver operating characteristic (ROC) curve analysis was applied to evaluate the diagnostic performance. Results Age, serum ALT and AST levels in 50 patients with SLF were significantly older or higher, while peripheral blood platelet count was significantly lower than in 47 patients with non-SLF(P<0.05); SWV, APRI and FIB-4 scores, and serum HA level in patients with SLF were (2.1±0.4)m/s, (1.2±0.7), (2.0±1.0) and 132.2(95.4,210.5)ng/ml, all much higher than [(1.3±0.3)m/s, (0.6±0.3), (1.0±0.4) and 55.2(38.4,72.6)ng/ml, respectively, P<0.05] in those with non-SLF; the AUC was 0.94(95%CI:0.90-0.97), with sensitivity of 91.5% and specificity of 86.0%, when SWV was combined with any other fibrosis index mentioned above in predicting SLF in patients with CHB. Conclusion Combination of SWV with other liver fibrosis index commonly used could help clinicians screen liver fibrosis in patients with CHB, which warrants further investigation.

Key words: Hepatitis B, Acoustic radiation force impulse-based tissue quantification, Shear wave velocity, Aspartate aminotransferase-to-platelet ratio index, Fibrosis index based on four factors, Hyaluronic acids, Diagnosis